Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serotonin 5-hydroxytryptamine receptor 5A is a G protein-coupled receptor and one of the subtypes within the serotonin receptor family. Its primary function involves mediating the effects of serotonin in the central nervous system, contributing to signal transduction and neuronal regulation. The gene for 5-HT5A is functionally expressed in the human brain, while the related 5-HT5B subtype is non-functional in humans due to gene disruption. Although less studied than other serotonin receptors, 5-HT5A may be involved in modulating mood and cognitive functions, and experimental evidence suggests potential relevance to neurological and psychiatric disease, but it is not a major clinical drug target at present.
Antagonism or agonism at the receptor to modulate serotonin neurotransmission. Modulation of G protein signaling pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin 5-hydroxytryptamine receptor 5A (5-HT5A).